Efficacy and Safety of ABT-126 in Subjects with Mild-to-Moderate Alzheimer’s Disease on Stable Doses of Acetylcholinesterase Inhibitors: A Randomized, Double-Blind, Placebo-Controlled Study

2016 ◽  
Vol 51 (4) ◽  
pp. 1237-1247 ◽  
Author(s):  
Hana Florian ◽  
Andreas Meier ◽  
Serge Gauthier ◽  
Stanley Lipschitz ◽  
Yunzhi Lin ◽  
...  
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Acetylcholinesterase Inhibitors ◽  
Controlled Study ◽  
Efficacy And Safety ◽  
Double Blind ◽  
Double Blind Placebo

scholarly journals Oral curcumin for Alzheimer's disease: tolerability and efficacy in a 24-week randomized, double blind, placebo-controlled study

2012 ◽  
Vol 4 (5) ◽  
pp. 43 ◽  
Author(s):  
John M Ringman ◽  
Sally A Frautschy ◽  
Edmond Teng ◽  
Aynun N Begum ◽  
Jenny Bardens ◽  
...  
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Controlled Study ◽  
Double Blind ◽  
Double Blind Placebo

DHEA treatment of Alzheimer's disease: A randomized, double-blind, placebo-controlled study

Neurology ◽  
2003 ◽  
Vol 60 (7) ◽  
pp. 1071-1076 ◽  
Author(s):  
O.M. Wolkowitz ◽  
J.H. Kramer ◽  
V.I. Reus ◽  
M.M. Costa ◽  
K. Yaffe ◽  
...  
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Controlled Study ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Dhea Treatment
Sign in / Sign up

Export Citation Format

Share Document